DK175382B1 - Terpene flavorings - Google Patents

Terpene flavorings Download PDF

Info

Publication number
DK175382B1
DK175382B1 DK198805892A DK589288A DK175382B1 DK 175382 B1 DK175382 B1 DK 175382B1 DK 198805892 A DK198805892 A DK 198805892A DK 589288 A DK589288 A DK 589288A DK 175382 B1 DK175382 B1 DK 175382B1
Authority
DK
Denmark
Prior art keywords
mutant
ergosterol
process according
adh
cerevisiae
Prior art date
Application number
DK198805892A
Other languages
Danish (da)
Other versions
DK589288D0 (en
DK589288A (en
Inventor
Francis Karst
Barbu Dinu Vladimir Vladescu
Original Assignee
Pernod Ricard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pernod Ricard filed Critical Pernod Ricard
Publication of DK589288D0 publication Critical patent/DK589288D0/en
Publication of DK589288A publication Critical patent/DK589288A/en
Application granted granted Critical
Publication of DK175382B1 publication Critical patent/DK175382B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/70Clarifying or fining of non-alcoholic beverages; Removing unwanted matter
    • A23L2/84Clarifying or fining of non-alcoholic beverages; Removing unwanted matter using microorganisms or biological material, e.g. enzymes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/20Synthetic spices, flavouring agents or condiments
    • A23L27/24Synthetic spices, flavouring agents or condiments prepared by fermentation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12GWINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
    • C12G1/00Preparation of wine or sparkling wine
    • C12G1/06Preparation of sparkling wine; Impregnation of wine with carbon dioxide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12GWINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
    • C12G3/00Preparation of other alcoholic beverages
    • C12G3/02Preparation of other alcoholic beverages by fermentation
    • C12G3/021Preparation of other alcoholic beverages by fermentation of botanical family Poaceae, e.g. wheat, millet, sorghum, barley, rye, or corn
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12GWINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
    • C12G3/00Preparation of other alcoholic beverages
    • C12G3/02Preparation of other alcoholic beverages by fermentation
    • C12G3/025Low-alcohol beverages
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/02Preparation of oxygen-containing organic compounds containing a hydroxy group
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/02Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/04Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Fats And Perfumes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Process for obtaining terpenic aromas, characterised in that a mutant of S. cerevisiae blocked in the route for the synthesis of the ergosterol which secretes aromatic terpenes is cultured on an appropriate culture medium. This process can be employed more particularly for the production of aromatised beverages.

Description

DK 175382 B1 iDK 175382 B1 i

Den foreliggende opfindelse angår en fremgangsmåde til fremstilling af terpen-aromastoffer, isar til aromatiserlng af drikkevarer, ved en mikrobiologisk proces, hvorved der benyttes Saccharomyces cerevisiae-mutanter.The present invention relates to a process for the preparation of terpene flavors, particularly to flavoring beverages, by a microbiological process using Saccharomyces cerevisiae mutants.

5 Terpener, der i det væsentlige betragtes som produkter af vegetabilsk oprindelse, er karakteristiske bestanddele i flere essentielle olier. v På grund af deres fysiologiske og sensoriske egenskaber har mono· og sesquiterpeneme mange anvendelsesområder inden for levnedsmiddel· industrien, parfumeindustrien og den farmaceutiske industri.5 Terpenes, considered essentially as products of vegetable origin, are characteristic constituents of several essential oils. v Due to their physiological and sensory properties, the mono · and sesquiterpenes have many applications in the food industry, the perfume industry and the pharmaceutical industry.

10 Desuden er visse monoterpener (geraniol, nerol, linalol, citronellol, alfa-terpineol) ansvarlige for den aromatiske karakter hos muskatdruen. Druevarieteterne med muskatsmag og -aroma tilhører to forskellige klasser, der hovedsagelig defineres ved værdien af forholdet mellem linalol og geraniol. For "Muscat"-varieteterne er forholdet 15 mellem linalol og geraniol større end 1, mens det er klart mindre end 1 for "Malvoisie"-varieteterne.In addition, certain monoterpenes (geraniol, nerol, linalol, citronellol, alpha-terpineol) are responsible for the aromatic nature of the nutmeg. The grape varieties with nutmeg flavor and aroma belong to two different classes, mainly defined by the value of the ratio of linalol to geraniol. For the "Muscat" varieties, the ratio of linalol to geraniol is greater than 1, while it is clearly less than 1 for the "Malvoisie" varieties.

Selv om de vegetabilske kilder til monoterpener er talrige, kan de af klimatiske, sæsonmæssige, økonomiske og politiske årsager vise sig at være utilstrækkelige stillet over for et mere og mere krævende mar-20 ked, og derfor har den mikrobielle fremstilling af disse aromatiske stoffer en betydelig interesse, hvilket er ét af formålene med den foreliggende opfindelse.Although the vegetable sources of monoterpenes are numerous, for climatic, seasonal, economic and political reasons, they may prove insufficient for an increasingly demanding market, and therefore the microbial production of these aromatics has a considerable interest, which is one of the objects of the present invention.

I modsætning til filamentøse fungi, hvis evne til at syntetisere terpener ofte er blevet beskrevet, synes gær at mangle disse biosyn-25 tetiske evner. De få gærarter, for hvilke der er beskrevet en produktion af terpener (i form af spor), er faktisk alle ikke-cerevisi-4 ae-arter.Unlike filamentous fungi, whose ability to synthesize terpenes has often been described, yeast appears to lack these biosynthetic capabilities. Indeed, the few yeast species for which a production of terpenes (in the form of traces) have been described are all non-cerevisi-4 ae species.

Gærs, især S. cerevisiae's, ringe produktion af terpener står tilsyneladende i modsætning til deres tilstedeværelse i celler med en-30 zymatiske systemer, der er i stand til at katalysere biosyntese af visse monoterpener.Yeast, especially S. cerevisiae's, low production of terpenes apparently stands in contrast to their presence in cells with enzymatic systems capable of catalyzing the biosynthesis of certain monoterpenes.

DK 175382 B1 IDK 175382 B1 I

$. cerevisiae-celler syntetiserer nemlig betydelige mængder (0.5-3Z I$. namely, cerevisiae cells synthesize significant amounts (0.5-3Z I

af tørvagten) ergosterol ud fra acetyl-CoA, og polymeriseringen af Iof the dry watch) ergosterol from acetyl-CoA, and the polymerization of I

acetyl*CoA sker som hos højerestående planter via mevalonat, geranyl· Bacetyl * CoA occurs as in higher plants via mevalonate, geranyl · B

pyrophosphat og farnesylpyrophosphat. S. cerevisiae har således alle Ipyrophosphate and farnesyl pyrophosphate. Thus, S. cerevisiae has all I

5 de enzymer, der er nødvendige for biosyntesen af terpener, og grunden B5 the enzymes necessary for the biosynthesis of terpenes, and the reason B

til, at disse sidstnævnte ikke udskilles, er sandsynligvis, at enzy* Ito which these latter are not excreted, it is probable that enzy * I

mer fra ergosterol-syntesevejen har en kraftig affinitet for terpen- Bmore from the ergosterol synthesis pathway has a strong affinity for terpene-B

pyrophosphaterne, som således i det væsentlige polymeriseres til 1 Bthe pyrophosphates, which are thus substantially polymerized to 1 B

ergosterol. Iergosterol. IN

10 Pen foreliggende opfindelse bygger på den erkendelse, at visse S. BThe present invention is based on the recognition that certain S. B

cerevisiae-mutanter er i stand til at udskille terpener i modsætning Bcerevisiae mutants are capable of secreting terpenes in opposition B

til det, som hidtil har varet erkendt, og disse stammer kan desuden Bto that which has hitherto been recognized, and these strains may additionally B

anvendes til direkte fremstilling af fermenterede eller ikke-fermen- Iused for the direct manufacture of fermented or non-fermented I

terede aromatiske drikkevarer. Baromatic beverages. B

15 Den foreliggende opfindelse angår specifikt en fremgangsmåde til IThe present invention specifically relates to a method for I

fremstilling af terpen-aromastoffer, ved hvilken fremgangsmåde en S. Ipreparation of terpene flavorings by which process a S. I

cerevisiae-mutant, som er blokeret i ergosterol-syntesevejen, og som Bcerevisiae mutant which is blocked in the ergosterol synthesis pathway and which B

udskiller aromatiske terpener, dyrkes på et hensigtsmæssigt dyrk- Isecretes aromatic terpenes, is grown on an appropriate cultivar

ningsmedium. Iup medium. IN

20 Takket være de undersøgelser, der har ført til den foreliggende op- I20 Thanks to the studies that have led to the present op

findelse, har det faktisk kunnet påvises, at biosyntesen af ergoste- IIn fact, it has been shown that the biosynthesis of ergot I

rol, der er blokeret af mutationer i visse trin, for visse stammer (i Irole blocked by mutations in certain steps, for certain strains (in I

det følgende betegnet ergosterol-auxotrofe mutanter) viser sig ved Bhereinafter termed ergosterol auxotrophic mutants) appears at B

akkumulering af terpen-mellemprodukter. De mutationer, der påvirker Iaccumulation of terpene intermediates. The mutations affecting I

25 syntesevejen for steroler i gærstamoen S. cerevisiae, og som oftest BThe pathway of synthesis for sterols in the yeast strain S. cerevisiae, and most often B

viser sig ved akkumulering af terpen-pyrophosphater, svarer til bio- Bshown by the accumulation of terpene pyrophosphates, corresponds to bio-B

kering i de trin, der katalyseres af squalen-synthetase og famesyl- Bin the steps catalyzed by squalene synthetase and famesyl-B

diphosphatsynthase (EC 2.5.1.10). v Bdiphosphate synthase (EC 2.5.1.10). v B

Stammer af denne type kan selekteres ved mutation af Saccharomyces- BStrains of this type can be selected by Saccharomyces-B mutation

30 stammer og selektion på et medium, der indeholder en sterol, især B30 strains and selection on a medium containing a sterol, especially B

ergosterol, og nystatin. flergosterol, and nystatin. fl

På grund af ergosterol-auxotrofien udviser visse af disse stammer, fx BDue to the ergosterol auxotrophy, some of these strains exhibit, e.g., B

stammen 134, som beskrives nærmere i eksemplerne, Imidlertid i visse Bstrain 134, which is further described in the Examples, however, in certain B

DK 175382 B1 3 tilfælde en relativt svag vækst på grund af et generelt meget lavt sterolindhold i frugtsaften. For at afhjælpe de ofte betydelige kvalitative og kvantitative fluktuationer, som iagttages, når denne gærtype lades fermentere, kan der især ved subkloning fås stammer, 5 der foruden de ovenfor beskrevne mutationer omfatter en suppressormu-' tation, som viser sig ved vækst i fravær af ergosterol.DK 175382 B1 3 cases a relatively weak growth due to a generally very low sterol content in the fruit juice. In order to alleviate the often significant qualitative and quantitative fluctuations observed when this yeast type is fermented, strains can be obtained, in particular, by subcloning, which, in addition to the mutations described above, comprises a suppressor mutation which appears in growth in the absence of ergosterol.

vv

Den partielle suppression af ergosterol-auxotrofien fører til genoprettelse af vildtype-fænotypen.The partial suppression of the ergosterol auxotrophy leads to restoration of the wild-type phenotype.

Ved tetrade-analyse har man kunnet fastslå, at 10 - mutationen segregerer uafhængigt af ergosterol-auxotrofi; mutationen kan isoleres fra rekombinante sporer, der er ergoste-rol-prototrofe; - mutationen er recessiv.By tetrade analysis, it has been established that the 10 - mutation segregates independently of ergosterol auxotrophy; the mutation can be isolated from recombinant spores which are ergoste-role prototrophs; - the mutation is recessive.

Få trods af deres relative uafhængighed af exogen ergosterol produ-15 cerer disse kloner alligevel betydelige mængder monoterpener.However, despite their relative independence of exogenous ergosterol, these clones produce significant amounts of monoterpenes.

Denne type stammer kan fx selekteres ved subkloning af foregående stammer på et medium uden ergosterol.For example, this type of strains may be selected by subcloning the preceding strains onto a medium without ergosterol.

Det skal bemærkes, at disse stammer syntetiserer ergosterol i begrænset omfang, og at de kan vokse i fravær af ergosterol, men at 20 denne mutation ikke påvirker blokeringen i sterolsyntesevejen og ikke manifesterer sig fænotypisk i erg+-afkommet.It should be noted that these strains synthesize ergosterol to a limited extent and that they may grow in the absence of ergosterol, but that this mutation does not affect blockage in the sterol synthesis pathway and does not manifest phenotypically in the erg + progeny.

For at sikre genetisk stabilitet hos erg*-mutanterne bevares de i he-terozygot tilstand i form af erg'/erg+-diploider. Før anvendelse iso- \t.To ensure genetic stability of the erg * mutants, they are conserved in heterozygous state in the form of erg / erg + diploids. Before use iso- \ t.

leres erg'-sporerne efter sporulering og dissektion af sporesækkene. 1the erg 'traces are learned after sporulation and dissection of the trace sacs. 1

Ved anvendelse af denne fremgangsmåde har det vist sig, at visse erg*-stammer, som efter sporulering fremkom fra erg*/erg+-diploider-ne, ikke mere udskilte terpener i mediet. Dette har ført til påvisning af en yderligere recessiv mutation, som i forbindelse med blokeringen i sterolsyntesevejen muliggør udskillelse af terpener.Using this method, it has been found that certain erg * strains which, after sporulation, emerged from the erg * / erg + diploids, no longer excreted terpenes in the medium. This has led to the detection of a further recessive mutation which, in connection with the blocking of the sterol synthesis pathway, allows the excretion of terpenes.

I DK 175382 B1 II DK 175382 B1 I

I 4 II 4 I

De mest interessante mutanter ifølge opfindelsen skal således for· IThus, the most interesting mutants according to the invention are for I

I trinsvis foruden de ovenfor nævnte mutationer bære en mutation, som IIn addition to the above mentioned mutations, you carry a mutation which I

I betegnes ter. og som enten er impliceret i permeabilisering af mem· IYou are referred to as ter. and which are either implicated in the permeabilization of mem · I

branen eller i dephosphorylering af geranylpyrophosphat. Ithe brane or in the dephosphorylation of geranyl pyrophosphate. IN

I 5 I de rekombinante erg+-haploider manifesterer ter-mutationen sig ikke IIn the recombinant erg + haploids, the ter mutation does not manifest itself

I fænotypisk. De erg*-sporer, der stammer fra diploideme erg+ ter/erg* IIn phenotypic. The erg * spores derived from the diploid erg + ter / erg * I

I ter, producerer stadig terpener. « IIn ter, still produce terpenes. «I

Mutanter, der producerer terpener, bør bevares i heterozygot tilstand IMutants producing terpenes should be retained in heterozygous state I

med en stamme, der bærer ter-mutationen. som erg+-forældre. Iwith a strain carrying the ter mutation. as erg + parents. IN

10 Blandt de foretrukne mutanter ifølge opfindelsen skal nævnes de mu- IAmong the preferred mutants of the invention, mention should be made of the mouse

tanter, der bærer følgende mutationer: Iaunts carrying the following mutations:

I - erg-, blokering i syntesetrinnene for steroler, hvilke trin kata- II - irritation, blockage in the synthesis steps of sterols, which steps are categorized

I lyseres af farnesylpyrophosphat-synthetase og squalen-synthetase, IYou are lysed by farnesyl pyrophosphate synthetase and squalene synthetase, I

I - en recessiv suppressor, som ikke har forbindelse med erg*-mutatio- II - a recessive suppressor which is not associated with erg * mutation- I

I 15 nen, og som meddeler en relativ uafhængighed af exogen ergosterol IIn the nene, and which indicates a relative independence of exogenous ergosterol I

I uden at påvirke blokeringen i syntesevejen for steroler, IWithout affecting the blockage of the synthesis pathway for sterols,

I - ter. en recessiv mutation, der muliggør produktion af terpener, II - ter. a recessive mutation that allows the production of terpenes, I

uden hvilken det geranylpyrophosphat, der er akkumuleret på grund Iwithout which the geranyl pyrophosphate accumulated due to I

I af erg*-blokeringen, ikke udskilles i mediet i form af geraniol. II of the erg * blocker, is not excreted in the medium in the form of geraniol. IN

20 De således vundne stammer udskiller aromatiske terpener i betydelige IThe strains thus obtained secrete aromatic terpenes into considerable I

mængder, men nærværende ansøger har kunnet, påvise muligheden for at Iquantities, but this applicant has been able to demonstrate the possibility that you

I forøge denne udskillelse yderligere. IYou further increase this separation. IN

I De foretagne undersøgelser har nemlig vist, at alkohol-dehydrogena- IThe studies carried out have shown that alcohol dehydrogenase I

I seme (ADH) udviser en forøget produktion af acetyl-CoA, hvilket gør IIn seme (ADH), an increased production of acetyl-CoA exhibits, as do I

25 det muligt at forøge aktiviteten af syntesevejen for steroler, idet * IIt is possible to increase the activity of the synthesis pathway for sterols, with * I

I en større mængde acetyl-CoA står til rådighed. " IA larger amount of acetyl-CoA is available. "I

I Især er følgende mutationer interessante: IIn particular, the following mutations are interesting:

I - ADH I'-mutanter, dvs. mutanter, der mangler fermenterings-isoen- II - ADH I mutants, viz. mutants lacking the fermentation iso- I

I zym, og som ikke er i stand til at danne ethanol ud fra acetal- IIn zym and which are unable to form ethanol from acetal-I

I 30 dehyd og dermed udviser en forøget produktion af acetyl-CoA; IIn 30 dehydes and thus exhibits increased production of acetyl-CoA; IN

DK 175382 B1 5 • ADH Ile-mutanter, dvs. konstltutlve mutanter for oxidativt isoen-zym, som oxiderer ethanol til acetaldehyd, selv 1 nærværelse af store mængder sukker (en typisk betingelse for frugtsaft og .most), mens vildtypestammen kun oxiderer ethanol i fravær af 5 sukker.• ADH Ile mutants, ie. constitutive mutants for oxidative isoenzyme which oxidize ethanol to acetaldehyde, even in the presence of large amounts of sugar (a typical condition of fruit juice and must), while the wild-type strain only oxidizes ethanol in the absence of 5 sugars.

iin

En kombination af disse forskellige mutationer gør det især muligt at ' få mutanter, der producerer terpener i store mængder, især terpener af aromatisk interesse såsom farnesol og geraniol.In particular, a combination of these different mutations makes it possible to obtain mutants producing terpenes in large quantities, especially terpenes of aromatic interest such as farnesol and geraniol.

De mutanter, der især er interessante, er de mutanter, der er ergo-10 sterol-auxotrofe og ADH Ile, de mutanter, der er ergosterol-auxotrofe og ADH I', og endelig mutanterne ADH 1' samt ADH 11c.The mutants of particular interest are the mutants which are ergo-sterol auxotrophs and ADH Ile, the mutants that are ergosterol auxotrophs and ADH I ', and finally the mutants ADH 1' and ADH 11c.

Frémgangsmåden ifølge den foreliggende opfindelse kan udøves på forskellig måde.The method of the present invention can be practiced in various ways.

Først og fremmest er det muligt at anvende en kultur af denne mutant-15 type til fremstilling af aromastoffer såsom aromastoffer af naturlig Muscat, som oprenses ud fra kulturen, og som kan anvendes til aroma-tisering af levnedsmiddelsubstrater, især drikkevarer.First of all, it is possible to use a culture of this mutant type to produce flavors such as natural Muscat flavors which are purified from the culture and which can be used to flavor food substrates, especially beverages.

I de fleste tilfælde fremstilles terpen·aromastofferne Imidlertid direkte in situ ved dyrkning af levnedsmiddelsubstrater, især lev-20 nedsmiddelvæsker eller levnedsmiddelprodukter, som kan gøres flydende såsom fx frugtpuréer. I dette tilfælde fermenteres disse substrater direkte af S. cerevisiae-mutantstammeme, som således sørger for aromatisering af substraterne.In most cases, however, the terpenic flavors are produced directly in situ by growing food substrates, especially food liquids or food products, which can be liquified such as, for example, fruit purees. In this case, these substrates are fermented directly by the S. cerevisiae mutant strains, thus providing for the aromatization of the substrates.

I det tilfælde, hvor den anvendte mutant er en ADH I'-mutant, dvs. en 25 mutant, der ikke indeholder fermentativ alkohol-dehydrogenase, er de opnåede fermenteringsprodukter ikke-alkoholiserede produkter eller produkter med en meget lav alkoholstyrke.In the case where the mutant used is an ADH I mutant, i.e. a mutant which does not contain fermentative alcohol dehydrogenase, the obtained fermentation products are non-alcoholic products or products with a very low alcoholic strength.

I visse tilfælde kan det naturligvis være interessant at lade denne type stamme fermentere medier, der allerede er alkoholiserede, for at 50 give dem visse aromaer, og i dette tilfælde kan der udføres successive fermenteringer med en gær, der producerer alkohol, og derefter medOf course, in some cases it may be interesting to allow this type of strain to ferment media that is already alcoholic to give them certain aromas, and in this case successive fermentations may be carried out with a yeast producing alcohol and then with

I DK 175382 B1 II DK 175382 B1 I

I II I

I mutanter ifølge den foreliggende opfindelse, eller når det er muligt IIn mutants of the present invention, or whenever possible I

I eller foreneligt med gerstammernes vækst, at udføre en cofermentering IIn or compatible with the growth of yeast strains, to perform a cofermentation

I med de to gerstammer. Disse gerstammer kan også anvendes til udførel- IIn with the two gerbils. These yeast strains can also be used for export

se af flaskegering, fx i mousserende vine. Isee of bottling, for example in sparkling wines. IN

I 51 mange tilfælde kan fremstillingen af alkoholiserede og aromatisere- IIn 51 many cases, the preparation of alcoholic and aromatized I

de drikke naturligvis udføres under anvendelse af en mutant ifølge Ithe beverages are of course carried out using a mutant of I

I opfindelsen, der imidlertid indeholder en fermentativ alkohol-dehy- < IIn the invention, however, which contains a fermentative alcohol dehy- <1

I drogenase (ADH I+). IIn drugase (ADH I +). IN

I Da stammerne ifølge den foreliggende opfindelse for nogles vedkommen* IIn the strains of the present invention for some people * I

I 10 de er ergosterol-auxotrofe, er det, når dyrkningsmediet er et fuld- IWhen they are ergosterol auxotrophic, it is when the culture medium is a full I

I stendig syntetisk medium, nødvendigt at sørge for tilsætning af ergo- IIn constant synthetic medium, it is necessary to provide the addition of ergo- I

I sterol for at sikre gerstammemes vækst. I tilfælde af substrater af IIn sterol to ensure the growth of gerber strains. In the case of substrates of I

I vegetabilsk oprindelse er en sådan tilsætning generelt ikke nødven- IIn vegetable origin, such an additive is generally not necessary

dig, fordi disse forbindelser findes som sporelementer i de forskel- Iyou, because these compounds exist as trace elements in the differences I

I 15 lige vegetabilske ekstrakter. IIn 15 equal vegetable extracts. IN

I De forsøg, der er udført ved hjælp af mutanterne ifølge den fore- IIn the experiments performed using the mutants of the present invention

I liggende opfindelse, har vist, at det således var muligt fx at opnå IThe present invention has shown that it was thus possible, for example, to obtain I

I ikke-alkoholiserede frugtsafter, som havde den for Muscater karak- IIn non-alcoholic fruit juices which had it for Muscater character

I teristiske aroma, eller alkoholiserede produkter af vintypen eller IIn teristic aroma, or alcoholic products of the wine type or I

I 20 den mousserende vintype, som havde de for Muscat eller Kalvoisie IIn 20 the sparkling wine type they had for Muscat or Kalvoisie I

I karakteristiske aromaer. IIn distinctive aromas. IN

I Mutanterne ADH I* eller ADH Ile er for deres vedkommende særlig IIn the mutants ADH I * or ADH Ile, in particular, are I

I interessante ved fremstilling af steroler, især ergosterol, og gene- IOf interest in the preparation of sterols, especially ergosterol, and gene I

I relt ved de produkter, der indebærer en forøget mængde acetyl-CoA. IIn the case of products containing an increased amount of acetyl-CoA. IN

I 25 Opfindelsen belyses nærmere ved nedenstående eksempler. IThe invention is further illustrated by the following examples. IN

I II I

I EKSEMPEL 1 IIn Example 1 I

I Fremstilling af en ADH I~-mutant IIn Preparation of an ADH I ~ Mutant I

I Mutanten FL 100 ADH I' selekteres ud fra den haplolde vildtypes tamme IIn the mutant FL 100 ADH I 'is selected from the domestic I of the haplolled wild type

I FL 100 (ATCC 28383) ved resistens over for allylalkohol i nærværelse IIn FL 100 (ATCC 28383) by resistance to allyl alcohol in presence I

DK 175382 B1 7 af glucose. Denne mutant, som er ergosterol-prototrof, akkumulerer ikke terpen-mellemprodukter, idet alle trinnene i syntesevejen for steroler er funktionelle.DK 175382 B1 7 of glucose. This mutant, which is ergosterol prototrophic, does not accumulate terpene intermediates, as all steps in the synthesis pathway for sterols are functional.

Derimod viser den forøgede mængde acetyl-CoA, der skyldes ADH I*· 5 mutationen, sig ved en betydelig forøgelse i mængden af syntetiseret ergosterol (tabel 1). Denne type mutanter udgør stammer, der hyper* producerer ergosterol.In contrast, the increased amount of acetyl-CoA due to the ADH I * 5 mutation is shown by a significant increase in the amount of synthesized ergosterol (Table 1). This type of mutant forms strains that hyper * produce ergosterol.

TABEL 1TABLE 1

Ergosterol 10 (X af tarvæpten^ FL 100 0,75 ± 0,06 FL 100 ADH 1' 1,06 ± 0,05 EKSEMPEL 2Ergosterol 10 (X of the wheat gun ^ FL 100 0.75 ± 0.06 FL 100 ADH 1 '1.06 ± 0.05 EXAMPLE 2

Fremstilling af en mutant, der er ergosterol-auxotrof 15 Der foretages en mutagenese ved hjælp af ultraviolette stråler af vildtypestammen FL 100.Preparation of a mutant that is ergosterol auxotroph 15 Mutagenesis is performed by ultraviolet rays of the wild-type strain FL 100.

Derefter selekteres de stammer, der er resistente over for nystatin i nærværelse af ergosterol. Blandt de resistente mutanter selekteres én, som betegnes "mutant erg 9".Next, the strains resistant to nystatin in the presence of ergosterol are selected. Among the resistant mutants, one is selected, termed "mutant erg 9".

20 Denne mutants auxotrofi bekræftes på et komplet medium (IX gærekstrakt, IX bactopeptone, 2X glucose) med eller uden ergosterol (80 /ig/ml).The auxotrophy of this mutant is confirmed on a complete medium (IX yeast extract, IX bactopeptone, 2X glucose) with or without ergosterol (80 µg / ml).

Måling af squalen-synthetase-aktiviteten udføres i den mikrosomale fraktion ved metoden ifølge Agnew og Popjak (W.S. Agnew, G. Popjak 25 (1978) J. Bio. Cheat. 253, 4566-4573), hvorved påvises, at denne mutant erg 9 mangler squalen-synthetase-aktivitet.Measurement of squalene synthetase activity is performed in the microsomal fraction by the method of Agnew and Popjak (WS Agnew, G. Popjak 25 (1978) J. Bio. Cheat. 253, 4566-4573), demonstrating that this mutant erg 9 lacks squalene synthetase activity.

I DK 175382 B1 II DK 175382 B1 I

i 8 Ii 8 I

I Mutanten erg 9 er ligeledes karakteristisk ved fravær af ADH I (ringe IIn the mutant erg 9 is also characteristic of the absence of ADH I (rings I

I produktion af ethanol) og ved konstitutivitet for ADH II. Dens fzno- IIn the production of ethanol) and by constitutivity for ADH II. Its fzno- I

type er angivet i tabel 2. Itype is given in Table 2. I

I TABEL 2 II TABLE 2 I

IIN

I 5 Vækst Squalen-synthetase ADH I ADH II Ethanol II 5 Growth Squalene synthetase ADH I ADH II Ethanol I

I YPG+erg YPG (s.a.) (s.a.) (s.a.) (g/1) II YPG + erg YPG (s.a.) (s.a.) (s.a.) (g / 1) I

I FL 100 +++ +++ 0,24 16,2 12,3 36,2 IIn FL 100 +++ +++ 0.24 16.2 12.3 36.2 I

I erg 9 ++ 0 0 10,8(*) 3,7 II very 9 ++ 0 0 10.8 (*) 3.7 I

10 _____ I10 _____ I

I s.a. - specifik aktivitet II s.a. - specific activity I

I (*) - i nærværelse af 90 g/1 glucose II (*) - in the presence of 90 g / l glucose I

I EKSEMPEL 3 IIn Example 3 I

I Fremstilling af en mutant, som er ergosterol-auxotrof II Preparation of a mutant which is ergosterol auxotroph I

I 15 Denne mutant blev opnået ud fra en varmefølsom mutant, der var gly- II This mutant was obtained from a heat sensitive mutant which was gly-I

I cin-auxotrof (aux 32 ts), efter UV-mutagenese på medium med nystatin. IIn cin auxotroph (aux 32 ts), after UV mutagenesis on medium with nystatin. IN

I Denne mutant akkumulerer dimethyl-allyl-pyrophosphat in vitro og II This mutant accumulates dimethyl-allyl pyrophosphate in vitro and I

I producerer ikke farnesylpyrophosphat i nærværelse af isopentenyl- IYou do not produce farnesyl pyrophosphate in the presence of isopentenyl-I

I pyrophat (mærket med carbon-14) og geranylpyrophosphat, hvilket tyder IIn pyrophate (labeled with carbon-14) and geranyl pyrophosphate, suggesting I

I 20 på fravær af farnesyl-diphosphat-synthase-aktivitet. II 20 in the absence of farnesyl diphosphate synthase activity. IN

I Desuden udviser mutanten 134 det for erg 9-stammer karakteristiske IIn addition, mutant 134 exhibits the characteristic of strain 9 strains I

I fænomen; den fænotypiske allelisme tyder på tilstedeværelse af en IIn the phenomenon; the phenotypic allelism suggests the presence of an I

I allel af erg 9; det drejer sig derfor om en dobbelt farnesyl-diphos- IIn allele of erg 9; it is therefore a double farnesyl diphos- I

I phat-synthase-mutant. t IIn phat synthase mutant. t I

I 25 I lighed med mutanten erg 9 er mutanten 134 konstitutiv ADH I* og ILike the mutant erg 9, the mutant 134 is constitutive ADH I * and I

I ADH II. Resultaterne for udskillelse af geraniol in vivo viser, at IIn ADH II. The results for the secretion of geraniol in vivo show that I

I mutationen farnesyl-diphosphat-synthase er bradytrof. IIn the mutation farnesyl diphosphate synthase is bradytrof. IN

9 EKSEMPEL 4 DK 175382 B1EXAMPLE 4 DK 175382 B1

De to mutanter erg 9 og 134 dyrkes 1 rystekultur (24 timer) eller stationer kultur (4 dage) i komplet medium (IX gærekstrakt, IX bac-topeptone, 2t glucose, 0,0081 ergosterol) ved 28eC. Disse to mutanter • 5 udskiller famesol og geraniol effektivt, hvilket fremgår af tabel 3.The two mutants erg 9 and 134 are grown 1 shake culture (24 h) or stations culture (4 days) in complete medium (IX yeast extract, IX bac-topeptone, 2 h glucose, 0.0081 ergosterol) at 28 ° C. These two mutants • 5 efficiently secrete famesol and geraniol, as shown in Table 3.

TABEL 3TABLE 3

Famesol Geraniol (Mg/100 ml) (Mg/100 ml) 10 Stationer Ryste Stationer Rvste FL 100 n.d. n.d. n.d. n.d.Famesol Geraniol (Mg / 100 ml) (Mg / 100 ml) 10 Stations Shaking Stations Rvste FL 100 n.d. n.d. n.d. n.d.

erg 9 24 138 n.d. n.d.bad 9 24 138 n.d. n.d.

134 17 40 - 22 15 n.d. «· ikke detekterbar134 17 40 - 22 15 n.d. «· Not detectable

Til sammenligning producerer vildtypestammen FL 100 hverken farnesol eller geraniol, hverken i rystekultur eller i stationer kultur.In comparison, the wild-type strain FL 100 produces neither farnesol nor geraniol, neither in shake culture nor in station culture.

EKSEMPEL 5EXAMPLE 5

Aromatisering af frugtsafter med mutanterne erg 9 og 134 20 Frugtkoncentrater (hvide druer, røde druer, hindbær, fersken, pære, banan) fortyndet med 120 g sukker/1 udstryges med 10^ cpm og inkuberes under agitation (150 omdr./minut) ved 30®C.Aromatization of fruit juices with the mutants erg 9 and 134 20 Fruit concentrates (white grapes, red grapes, raspberries, peaches, pear, banana) diluted with 120 g sugar / 1, smeared with 10 ^ cpm and incubated under agitation (150 rpm) at 30®C.

Den sensoriske analyse udføres efter 4 dage på safter, som er frigjort for celler. Lugteanalyser viser systematisk tegn på terpener i 25 tilfælde af mutanterne erg 9 og 134 til forskel fra de produkter, der er opnået ved hjælp af vildtypestammen FL 100. De iagttagne resultater er angivet i tabel 4.The sensory analysis is performed after 4 days on juices released for cells. Odor analyzes systematically show signs of terpenes in 25 cases of the mutants erg 9 and 134 as opposed to the products obtained by the wild-type strain FL 100. The observed results are reported in Table 4.

I DK 175382 B1In DK 175382 B1

I II I

I tabel 4 IIn Table 4 I

I FL 100 Erg 9 134 II FL 100 Erg 9 134 I

Hvid drue vinagtig muscat-type muscat-type IWhite grape wine-like muscat-type muscat-type I

Rød drue vinagtig blomsterduft blomsterduft IRed grape winey floral scent floral scent I

5 Fersken "gær" blomsterduft frugtagtig I5 Peach "yeast" flower fragrance fruity I

I Fære "gær* frugtagtig, frugtagtig, IIn the ferment "yeast * fruity, fruity, I

blomsteragtig blomsteragtig Ifloral floral I

Banan "gær" muscatduft, muscatduft IBanana "yeast" muscat fragrance, muscat fragrance I

I "famesol" IIn the "fame sun" I

I 10 Hindbær "gær", opløs- meget "fame- vinagtig duft IIn 10 Raspberries "yeast", very "famine-like" fragrance I

ningsmiddel sol"-agtig Isolvents-like I

EKSEMPEL 6 IEXAMPLE 6 I

H Ud fra stammen 134 fås ved subkloning en ny stamme, der er i stand IH From strain 134, a new strain capable of subcloning is obtained

15 til at vokse på et medium uden exogen ergosterol, og som har følgende I15 to grow on a medium without exogenous ergosterol and having the following I

karakteristika: ICharacteristics: I

- relativt god vækst uden ergosterol (mellemliggende niveau mellem I- relatively good growth without ergosterol (intermediate level between I

I 134 og vildtypestammen FL 100), II 134 and the wild type strain FL 100), I

- biosyntese af ergosterol (10X af vildtypestammen), I- biosynthesis of ergosterol (10X of the wild-type strain), I

H 20 blokering i det trin, der katalyseres af famesylpyrophosphat- IH 20 block in the step catalyzed by famesyl pyrophosphate-I

H synthetase, med akkumulering af geranylpyrophosphat, IH synthetase, with accumulation of geranyl pyrophosphate, I

- udskillelse i dyrkningsmediet af monoterpener, især geraniol og Iexcretion in the culture medium of monoterpenes, especially geraniol and I

I linalol. IIn linalol. IN

Denne stamme yder meget mere i industriel henseende og gør det muligt IThis strain provides much more in industrial terms and enables you to

I 25 at opnå stabile produktioner, både med hensyn til kvantitet og kvali' 4 IIn 25 to achieve stable productions, both in terms of quantity and quality

I tet. IIn tet. IN

Claims (13)

1. Fremgangsmåde til fremstilling af terpen-aromastoffer, kendetegnet ved, at en S. cerevisiae-mutant dyrkes på et hensigtsmæssigt dyrkningsmedium, hvilken mutant er blokeret i synte- ‘ 5 sevejen for ergosterol og udskiller aromatiske terpener.A process for the preparation of terpene flavorings, characterized in that a S. cerevisiae mutant is grown on an appropriate culture medium which is blocked in the synthesis pathway of ergosterol and secretes aromatic terpenes. 2. Fremgangsmåde ifølge krav 1, kendetegnet ved, at det hensigtsmæssige dyrkningsmedium omfatter en levnedsmiddelvæske eller et levnedsmiddelprodukt, der kan gøres flydende.Process according to claim 1, characterized in that the suitable culture medium comprises a liquid liquid or a liquid liquid food product. 3. Fremgangsmåde ifølge krav 1 eller 2, kendetegnet ved, at mutanten har en meget ringe squalen-synthetase-aktivitet og/eller farnesyldiphosphat-synthase-aktivitet.Method according to claim 1 or 2, characterized in that the mutant has a very low squalene synthetase activity and / or farnesyl diphosphate synthase activity. 4. Fremgangsmåde ifølge et hvilket som helst af kravene 1-3, kendetegnet ved, at S. cerevisiae-mutanten omfatter en 15 suppressormutation, som viser sig ved vækst i fravær af ergosterol.Method according to any one of claims 1-3, characterized in that the S. cerevisiae mutant comprises a suppressor mutation which is shown by growth in the absence of ergosterol. 5. Fremgangsmåde ifølge et hvilket som helst af kravene 1-A, kendetegnet ved, at mutanten er en ter-mutant.Method according to any one of claims 1-A, characterized in that the mutant is a ter mutant. 6. Fremgangsmåde ifølge krav 5, kendetegnet ved, at bevarelse af de mutanter, der anvendes 20 i fremgangsmåden, udføres i heterozygot tilstand med en stamme, der bærer ter-mutationen, som erg+-stamfader.Method according to claim 5, characterized in that the preservation of the mutants used in the process is carried out in heterozygous state with a strain carrying the ter mutation, as erg + progenitor. 7. Fremgangsmåde ifølge et hvilket som helst af kravene 1-6, kendetegnet ved, at mutanten er konstitutiv for oxidativ alkohol-dehydrogenase.Process according to any one of claims 1-6, characterized in that the mutant is constitutive of oxidative alcohol dehydrogenase. 8. Fremgangsmåde ifølge et hvilket som helst af kravene 1-7, kendetegnet ved, at mutanten mangler fermentativ alkohol-dehydrogenase. 1 Fremgangsmåde ifølge et hvilket som helst af kravene 1-8, kendetegnet ved, at mutanten er ADH I+. I DK 175382 B1 I I IProcess according to any one of claims 1-7, characterized in that the mutant lacks fermentative alcohol dehydrogenase. Method according to any of claims 1-8, characterized in that the mutant is ADH I +. I DK 175382 B1 I I I 10. Fremgsngsmi.de ifølge et hvilket som helst af kravene 1-9, I I kendetegnet ved, at terpen-aromastofferne ekstraheres fra I mediet efter dyrkning. IProcess according to any one of claims 1-9, characterized in that the terpene aromas are extracted from the medium after cultivation. IN 11. Fremgangsmåde ifølge et hvilket som helst af kravene 1-10, I 5 kendetegnet ved, at levnedsmiddelvasken er valgt blandt I H frugtsafter, mælk eller malkederivater og kommost. « IProcess according to any one of claims 1-10, characterized in that the food wash is selected from 1 H of fruit juices, milk or milk derivatives and cereals. «I 12. Fremgangsmåde ifølge et hvilket som helst af kravene 1-10, I H kendetegnet ved, at der fremstilles drikkevarer eller I aromatiserede produkter uden alkohol eller med et ringe alkoholind- I I 10 hold ved fermentering af udgangsprodukter med en ADH I‘-mutant af S. I cerevisiae, der er blokeret i biosyntesevejen for ergosterol. IProcess according to any one of claims 1 to 10, characterized in that beverages or aromatized products are produced without alcohol or with a low alcohol content by fermentation of starting products with an ADH I mutant of S In cerevisiae blocked in the biosynthetic pathway of ergosterol. IN 13. Fremgangsmåde ifølge krav 12, I kendetegnet ved, at mutanten er ADH Ile. IThe method of claim 12, characterized in that the mutant is ADH Ile. IN 14. Fremgangsmåde ifølge krav 13, I 15 kendetegnet ved, at S. cerevis iae-mutanten anvendes som I gær ved flaskegsring til fremstilling af mousserende vine. I I IProcess according to Claim 13, 15, characterized in that the S. cerevis iae mutant is used as a yeast in bottle ring to produce sparkling wines. I I I
DK198805892A 1987-10-22 1988-10-21 Terpene flavorings DK175382B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8714609A FR2622208B1 (en) 1987-10-22 1987-10-22 PROCESS FOR OBTAINING TERPENIC FLAVORS BY A MICROBIOLOGICAL PROCESS
FR8714609 1987-10-22

Publications (3)

Publication Number Publication Date
DK589288D0 DK589288D0 (en) 1988-10-21
DK589288A DK589288A (en) 1989-04-23
DK175382B1 true DK175382B1 (en) 2004-09-20

Family

ID=9356072

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198805892A DK175382B1 (en) 1987-10-22 1988-10-21 Terpene flavorings

Country Status (7)

Country Link
EP (1) EP0313465B1 (en)
AT (1) ATE88757T1 (en)
DE (1) DE3880619T2 (en)
DK (1) DK175382B1 (en)
ES (1) ES2054847T3 (en)
FR (1) FR2622208B1 (en)
IE (1) IE62461B1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992016611A1 (en) * 1991-03-12 1992-10-01 Pernod-Ricard Method of alcoholic fermentation to obtain muscat type aromas
DE19744212B4 (en) * 1997-09-30 2006-01-19 Schering Ag Process for the preparation of ergosterol and its intermediates by means of recombinant yeasts
EP2885420B1 (en) 2012-08-17 2018-12-05 Evolva SA Increased production of terpenes and terpenoids
FR3079845B1 (en) * 2018-04-10 2020-03-06 Clement Rozoy SPARKLING WINE FLAVORED WITH TERPENES

Also Published As

Publication number Publication date
DK589288D0 (en) 1988-10-21
EP0313465A1 (en) 1989-04-26
EP0313465B1 (en) 1993-04-28
DE3880619D1 (en) 1993-06-03
FR2622208A1 (en) 1989-04-28
FR2622208B1 (en) 1991-02-15
IE62461B1 (en) 1995-02-08
DK589288A (en) 1989-04-23
ATE88757T1 (en) 1993-05-15
IE883175L (en) 1989-04-22
DE3880619T2 (en) 1993-08-12
ES2054847T3 (en) 1994-08-16

Similar Documents

Publication Publication Date Title
Chatonnet et al. Synthesis of volatile phenols by Saccharomyces cerevisiae in wines
CN111378605B (en) Lactobacillus plantarum for biological deacidification of high-yield volatile ester compounds and application of lactobacillus plantarum in fruit wine
CN113717867B (en) Pichia pastoris capable of producing no ethanol and application thereof
Jane Lombardi et al. Yeast autolysis in sparkling wine aging: Use of killer and sensitive Saccharomyces cerevisiae strains in co-culture
CN113493746B (en) Yeast ZB431 and application thereof
Ingallinera et al. Effects of thermal treatments on pectinesterase activity determined in blood oranges juices
Estela-Escalante et al. Evaluation of the potential production of ethanol by Candida zemplinina yeast with regard to beer fermentation
Lu et al. Effects of sugar concentration on mango wine composition fermented by Saccharomyces cerevisiae MERIT. ferm
Budić-Leto et al. Fermentative aroma compounds and sensory descriptors of traditional Croatian dessert wine Prošek from Plavac mali cv.
DK175382B1 (en) Terpene flavorings
US11525109B2 (en) Strain of yeast Saccharomyces bayanus subsp. uvarum DBVPG36P, its use in the fermentative production of foods and a method for the selection of the strain
Calabretti et al. Characterization of volatile fraction of typical Irpinian wines fermented with a new starter yeast
Martin et al. Application of Hanseniaspora vineae to improve white wine quality
CN111363686B (en) Yeast for brewing aromatized wine and application and method thereof
Javelot et al. Introduction of terpene-producing ability in a wine strain of Saccharomyces cerevisiae
Takaya et al. Characterization of the yeast Hanseniaspora vineae isolated from the wine grape ‘Yamasachi’and its use for bread making
JPS626669A (en) Method of cultivating variant yeast
CN108342278A (en) A kind of tara vine wine and its brewing method
Samagaci et al. Polyphasic analysis of pectinolytic and stress-resistant yeast strains isolated from Ivorian cocoa fermentation.
EP1150581A1 (en) Fermented beverage and method for its production
JP4393028B2 (en) Novel yeast and its use
Ngwang The usage of banana (Musa Acuminata) for Novel beverage production
JP3932321B2 (en) Aroma-producing yeast, food and drink using the same, and method for producing the same
JP2670037B2 (en) Distilled liquor manufacturing method
JP3721383B2 (en) Muscat-like aroma-producing yeast, food and drink having Muscat-like aroma, and method for producing the same

Legal Events

Date Code Title Description
PUP Patent expired